We’re growing, but we can’t generate jobs,” KPMG chief economist Diane Swonk told Fortune. “Never seen anything like it.” ...

One of this era’s key questions in economics and finance has been - will the USD maintain its reserve status, and what does ...

Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty ...

Nigeria’s capital market is expected to sustain its bullish run last year through 2026, buoyed by ongoing banking sector ...

Eavor’s Geretsried project marks the first time a closed-loop geothermal system has delivered electricity to a commercial ...

We enter 2026 with richly valued equity markets. Check out six investments to keep your cash flows strong to remain an ...

Live Updates Get The Best Micron Technology Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Micron Technology, market updates, and brand-new stock ...

Oak Hill Bio and their partner are developing OHB-607, a recombinant human IGF-1/IGFBP-3 for the prevention of bronchopulmonary dysplasia in premature infants. Additional Oak Hill Bio assets that have ...

After decades of unchecked expansion, economic realities are forcing fairs to become more selective, more regional and more ...

Films in various Indian languages are gaining ground with better economics, and crossing linguistic and cultural boundaries ...

Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) -- XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine ...